Consensus 3SBio Inc.

Equities

1530

KYG8875G1029

Market Closed - Hong Kong S.E. Other stock markets 09:08:16 02/05/2024 BST			5-day change	1st Jan Change
6.58 ^HKD	+4.78%		+14.83%	-12.50%

04-22	3Sbio Inc. Announces Management Changes	CI
04-15	3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia	MT

Evolution of the average Target Price on 3SBio Inc.

Price target over the last 5 years

History of analyst recommendation changes

f348632694aacb1683dc3.tFR5DNwzRtZOc4uoazAzCy-cs9S5aNVTLIJpCVx_wDc.-2Qwe6hUM7oNAP7DRlsFPhnf4KboAJMHZ8MZMT0Xl0TnbCpL6XQO5SVHuw~5da6e06aaebe48d0ab72529f4f84e9e3

Analyst Recommendations on 3SBio Inc.

3SBio : MSCI ESG Rating Upgraded to A, Ranking at the Forefront of the Global Biotechnology Industry

01/09/20

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.812 CNY

Average target price

6.893 CNY

Spread / Average Target

+18.61%

High Price Target

8.837 CNY

Spread / Highest target

+52.05%

Low Price Target

5.707 CNY

Spread / Lowest Target

-1.80%

Consensus detail

Consensus revision (last 18 months)

Ratings for 3SBio Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar